BioTech 365

AUGUST 26, 2021

Sorrento Reports Promising Results With mRNA Vaccine For COVID-19 Delivered With The MuVaxx Lymphatic Drug Delivery Device Sorrento Reports Promising Results With mRNA Vaccine For COVID-19 Delivered With The MuVaxx Lymphatic Drug Delivery Device Sorrento’s mRNA vaccine (“STI-mRNA”) delivered with … Continue reading →

Drug Delivery 40

Drug Delivery Vaccination Vaccine Drugs 40

STAT News

NOVEMBER 3, 2022

… A Delaware federal court refused to throw out patent infringement claims brought by Arbutus Biopharma and Genevant Sciences against Moderna over its sale of Covid-19 vaccine doses to the U.S.  Genevant and Arbutus sued Moderna in February, seeking royalties from Moderna’s sale of its Covid-19 vaccine.

Vaccination 97

Vaccination Vaccine Drug Delivery Systems Sales 97

Scienmag

OCTOBER 15, 2020

Entos Pharmaceuticals announces launch of US-based spinout company Aegis Life, Inc.

Vaccination 52

Vaccination Vaccine Drug Delivery Medicine 52

XTalks

NOVEMBER 3, 2021

In this episode, Ayesha discusses the FDA’s authorization of Pfizer/BioNTech’s COVID-19 vaccine for children between five and 11 years of age. The editorial team discussed the positive trial data, the importance of vaccinating kids amid rising infections among younger children, as well as vaccine hesitancy among parents.

Life Science 52

Life Science Drug Delivery Systems Vaccination Vaccine 52

Roots Analysis

MARCH 16, 2023

In the last few years, researchers have become interested in using in vitro transcribed (IVT) mRNA as a drug delivery agent. It is worth noting that several companies have begun to develop mRNA-based cancer immunotherapies and vaccines for infectious diseases.

Vaccination 52

Vaccination Vaccine DNA Protein 52

pharmaphorum

MARCH 17, 2022

Alnylam claims it is owed a slice of the massive revenues booked by Pfizer and Moderna for their mRNA-based COVID-19 vaccines, because they are both infringing patents its holds on a delivery technology. The post Alnylam sues Pfizer, Moderna over COVID-19 vaccines appeared first on.

Vaccination 52

Vaccination Vaccine Sales Immune Response 52

XTalks

NOVEMBER 6, 2024

Gelteq centers its technology on a proprietary, customizable gel platform designed for precise drug delivery, supporting prescription drugs, nutraceuticals, pet care and sports supplements. Priced at $4.0

Drug Delivery 104

Drug Delivery Drugs Bioequivalency Bioavailability 104

Pharmaceutical Technology

JUNE 1, 2023

A new intracellular drug delivery centre will be established in the UK to support potential ribonucleic acid (RNA) vaccines and therapeutics , as well as the development of innovative drug delivery technologies. Another key focus area will be the creation of a framework to develop advanced nano-delivery systems.

Drug Delivery 242

Drug Delivery RNA Development Drugs 242

Roots Analysis

AUGUST 8, 2023

Furthermore, a wide variety of drugs and macromolecules, including DNA , proteins, and imaging agents, can be encapsulated in liposomal vesicles due to their unique ability to entrap both lipophilic and hydrophilic substances. The various therapeutic applications of liposomes in drug delivery have been highlighted in the figure.

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Drugs In-Vivo 52

pharmaphorum

FEBRUARY 3, 2022

There is a rising demand for vaccines, insulin, and many modern medicines used to treat cancer and other chronic diseases. As biologics are mainly administered through the injectable route, the significant growth in the biologics market is expected to drive the injectable drug delivery and prefilled syringe market in the coming years.

Drug Delivery 52

Drug Delivery Drugs Engineer Scientist 52

Pharmaceutical Technology

MAY 1, 2023

The successful launch of mRNA vaccines during the Covid-19 pandemic has not only spurred mRNA-related research across interdisciplinary groups, but also further validated the use of lipid nanoparticles as delivery approaches.

Drug Delivery 130

Drug Delivery Research Drugs Clinical Trials 130

Roots Analysis

OCTOBER 2, 2023

Owing to their unique size and physicochemical properties ( surface roughness, surface area, surface energy, crystal structure and shape ), nanoparticles can be widely used as a contrasting agent in medical imaging, a vesicle to cross the blood-brain barrier and a carrier for targeted delivery of genes / drugs, proteins, vaccines and antibiotics.

Drug Delivery 40

Drug Delivery Drugs Bioavailability Development 40

Roots Analysis

FEBRUARY 26, 2024

Given the robust pipeline of biologics, which include monoclonal antibodies, vaccines and other protein-based therapeutic products, subcutaneous medications are being investigated for various clinical candidates across different phases of development. You can also download the SAMPLE REPORT on subcutaneous medications by Roots Analysis.

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Drugs Contract Manufacturing 52

XTalks

NOVEMBER 5, 2024

Polyrizon’s focus on intranasal protection aligns with a rapidly expanding market in drug delivery innovation. The FDA-approved FluMist , featured as one of TIME’s Best Inventions of 2024, exemplifies the appeal of needle-free, self-administered nasal vaccines for influenza.

Drug Delivery 111

Drug Delivery Drugs Immune Response Allergies 111

Roots Analysis

MARCH 21, 2022

However, several drug delivery devices that enable patients to self-administer their respective medications are now available. Subcutaneous drug delivery systems – the helping hand for patients. The emergence of safer and patient-friendly devices is acting as a strong enabler for subcutaneous delivery of therapeutics.

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Antibody Drugs 52

pharmaphorum

OCTOBER 12, 2022

The 2023 Transdermal and Microneedle Drug Delivery Conference will explore real world applications of microneedles in drug delivery and strategies for advanced and user-centric device design. Regulation of transdermal delivery systems will be another key theme addressed, in combination with clinical trial optimization.

Drug Delivery 40

Drug Delivery Drugs Packaging Packaging 40

Pharmaceutical Technology

MARCH 22, 2023

This includes the rising number of biologic drugs on the market, which are mostly administered parenterally. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry. The injectable drugs market is currently valued at around $532 billion.

Contamination 130

Contamination Packaging Packaging Manufacturing 130

pharmaphorum

FEBRUARY 28, 2022

As part of SMi’s leading series of drug delivery device conferences, the 2022 event will provide insights into the rapidly accelerating market of combination product development with industry, device developer and regulatory perspectives. Uncover the key considerations to ensure optimal lifecycle management for drug delivery devices.

Drug Delivery 52

Drug Delivery Engineer Packaging Packaging 52

XTalks

MAY 24, 2023

RELATED: Walgreens, CVS, Amazon and Walmart Compete in Prescription Drug Delivery Factors Behind the CVS Health Clinical Trial Services Closure Speculations are rife in the industry for reasons behind the closure of CVS Health Clinical Trial Services.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Pharmacy 97

Pharmaceutical Technology

JUNE 23, 2022

During the peak of the Covid-19 pandemic this challenge reached new heights, as pharmaceutical firms around the world mobilised the full might of their resources to try and identify, develop, and trial a wide range of vaccines and therapeutics to alleviate the lethal threat posed by the virus. Decentralised trials continue to be in-demand.

Trials 130

Trials Clinical Trials Clinical Trials Drug Delivery 130

pharmaphorum

NOVEMBER 17, 2021

SMi presents the Inaugural: Transdermal and Microneedle Drug Delivery Conference. Latest innovations in drug delivery beyond the needle. SMi is proud to present the Transdermal and Microneedle Drug Delivery Conference, taking place on the 24th to 25th January 2022, in London. pharmaphorum .

Drug Delivery 52

Drug Delivery Drugs Vaccination Vaccine 52

pharmaphorum

JANUARY 18, 2022

The past year has seen significant developments in the injectables landscape with the rapid introduction and development of vaccines in response to the pandemic, updates in regulations including the EU MDR and FDA guidance on bridging studies, and increasing industry acceptance of connectivity to aid the user experience. 13.00 – 17.00.

Drug Delivery 52

Drug Delivery Production Drug Delivery Systems Packaging 52

Cloudbyz

MAY 15, 2023

For instance, if the trial involves a novel drug-delivery system, the DSMB might include a pharmaceutical scientist. The Role of DSMB in the COVID-19 Pandemic The importance of DSMBs was highlighted during the COVID-19 pandemic when several vaccines were developed and tested in clinical trials at record speed.

Clinical Trials 94

Clinical Trials Clinical Trials Trials Drug Delivery Systems 94

pharmaphorum

APRIL 28, 2022

Harness Safe & Efficacious Lipid-Based Delivery for Novel Therapeutics Beyond RNA & Hepatic Tissue. The recent success of the mRNA-LNP vaccines fueled biopharma to explore lipid-based nanoparticles for advanced drug delivery.

RNA 52

RNA Drug Delivery Engineer Gene Therapy 52

XTalks

OCTOBER 1, 2024

Overcoming the Challenges of mRNA Drug Development Developing mRNA therapeutics for respiratory conditions presents unique challenges, particularly in terms of drug delivery and stability.

Development 52

Development Drugs Immune Response Protein 52

Roots Analysis

OCTOBER 5, 2023

Driven by the increasing need for safe and efficient medical devices and drug delivery systems, the pharmaceutical polymers / medical grade polymers domain is advancing significantly. Vaccine Adjuvants: Polymers often serve as carriers for releasing the antigen and thereby regulating the immunological responses.

Manufacturing 40

Manufacturing Drug Delivery Systems Drug Delivery Packaging 40

Pharmaceutical Technology

FEBRUARY 15, 2023

The swift development and deployment of messenger-RNA (mRNA) vaccines against the SARS-CoV-2 virus during the COVID-19 crisis has catapulted the pharmaceuticals industry into a new paradigm. More challenges arise with the formulation of the mRNA delivery agent, like lipid nanoparticles (LNPs).

Bioassay 130

Bioassay RNA Development Drugs 130

pharmaphorum

SEPTEMBER 22, 2021

Abexxa will form part of its broad push into immuno-oncology, focused on cancer vaccines, oncolytic viruses and T-cell engagers, amongst other treatment strategies. Earlier this year, it backed out of a $600 million alliance with CureVac focused on developed mRNA-based vaccines for cancer. Last December, Boehringer paid €1.8

Antibody 92

Antibody Drug Delivery Vaccination Vaccine 92

Roots Analysis

FEBRUARY 18, 2022

Therefore, myeloid therapies have gained significant attention as a potential adjunct to currently used therapies, such as immune checkpoint inhibitors, dendritic cell vaccines, oncolytic viruses, and chemoradiation to enhance therapeutic response. Our Social Media Platform. Web: [link]. LinkedIn: [link]. Twitter: [link]. Medium: [link].

Drug Delivery Systems 52

Drug Delivery Systems Immune Response Clinical Trials Clinical Trials 52

Roots Analysis

FEBRUARY 20, 2022

In addition, in order to address the cell boundary challenge associated with the mRNA COVID-19 vaccines, majority of the deals in this industry have been inked for manufacturing lipid nanoparticles, required to envelop and deliver the mRNA (over 55%). Of these, 90% of the partnerships have been inked with industry players. Web: [link].

Contract Manufacturing 52

Contract Manufacturing Bioavailability Manufacturing Drug Delivery Systems 52

pharmaphorum

DECEMBER 15, 2022

Stefan Woxström is the new senior vice president for Europe and Canada at AstraZeneca, moving over from the company’s Japanese division to take over from Iskra Reic , who will now serve as EVP of vaccines and immune therapies. New CEO in at Angelini Pharma. More CEO shakeups.

Sales 52

Sales In-Vitro Antibody Drug Delivery 52

BioTech 365

OCTOBER 22, 2020

Synairgen’s SNG001 among the many potential treatments and vaccines to be delivered via Aerogen’s aerosol drug delivery system Adds to the thousands of COVID-19 patients already safely and effectively treated with Aerogen’s Solo aerosol drug delivery system in the intensive … Continue reading →

Drug Delivery Systems 40

Drug Delivery Systems Drug Delivery Development Vaccination 40

Roots Analysis

MARCH 13, 2022

In the last decade alone, the annual number of approvals of biopharmaceuticals (including monoclonal antibodies, recombinant proteins, vaccines and gene therapies), by the US FDA, have steadily risen. Over the years, the rising popularity of biologics has led to a paradigm shift in the healthcare industry. Our Social Media Platform.

Manufacturing 52

Manufacturing Drug Delivery Marketing Drug Delivery Systems 52

pharmaphorum

OCTOBER 18, 2021

The RNA therapeutics industry has grown at an exponential rate in recent years, with an increased spotlight following the industry’s leading role in developing vaccines against COVID-19 in response to the global pandemic. Delve into the latest innovations in novel RNA delivery and target specificity. Hashtag: #SMiRNA.

RNA 52

RNA Drug Delivery Scientist Clinical Development 52

pharmaphorum

JANUARY 12, 2023

Other than the oral insulin , Oramed is developing an oral formulation of a glucagon-like peptide-1 (GLP-1) analogue called ORMD-0901, but that remains in early clinical development, along with an oral COVID-19 vaccine.

Insulin 59

Insulin Trials Development Drugs 59

Pharmaceutical Technology

NOVEMBER 21, 2022

This will aid in the production of new raw materials and possible clinical-grade assets to develop mRNA vaccines and therapies for infectious diseases, as well as other ailments with unmet needs. RVAC is currently developing mRNA-based vaccines against infectious diseases such as Covid-19.

Manufacturing 130

Manufacturing Medicine Vaccination Vaccine 130

Roots Analysis

OCTOBER 22, 2023

In the last few years, researchers have become interested in using in vitro transcribed (IVT) mRNA as a drug delivery agent. Furthermore, these drug candidates can be used to develop precise and individualized therapies that allow patients to produce therapeutic proteins in their own bodies.

RNA 40

RNA Protein Genetics Gene Expression 40